4-hydroxy-2-methylbutan-2-yl acetate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-hydroxy-2-methylbutan-2-yl acetate
• 英文别名: (4-Hydroxy-2-methylbutan-2-yl) acetate
• 化学式: C₇H₁₄O₃
• 分子量: 146.186
• InChiKey: OPUPKMSXVSBMAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-hydroxy-2-methylbutan-2-yl acetate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 β-羟基异戊酸
  参考文献：
  名称：

  金（I）/铜（II）-共催化串联环化/ Semipinacol反应：6-Aza / Oxa-Spiro [4.5]癸烷骨架的构建和（±）-盐酸的形式合成

  摘要：

  提出了一种在金（I）/铜（II）的共催化下构建6-氮杂/氧杂-螺[4.5]癸烷骨架的简单有效策略，并且通过生物学上的正式合成证明了其潜在的实用性。活性海洋生物碱（±）-氯化氢。

  DOI：

  10.1002/adsc.201400932
• 作为产物：
  描述：

  原乙酸三甲酯 、 异戊二醇 在 对甲苯磺酸 作用下， 生成 4-hydroxy-2-methylbutan-2-yl acetate
  参考文献：
  名称：

  金（I）/铜（II）-共催化串联环化/ Semipinacol反应：6-Aza / Oxa-Spiro [4.5]癸烷骨架的构建和（±）-盐酸的形式合成

  摘要：

  提出了一种在金（I）/铜（II）的共催化下构建6-氮杂/氧杂-螺[4.5]癸烷骨架的简单有效策略，并且通过生物学上的正式合成证明了其潜在的实用性。活性海洋生物碱（±）-氯化氢。

  DOI：

  10.1002/adsc.201400932

文献信息

• AMINOPYRIMIDINE COMPOUND
  申请人：Cardurion Pharmaceuticals, LLC

  公开号：US20200095240A1

  公开（公告）日：2020-03-26

  The present invention provides a compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal arrhythmia) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有CaMKII抑制作用的化合物，预计可用作心脏疾病（特别是儿茶酚胺多形性室性心动过速、术后心房颤动、心力衰竭、致命性心律失常等）的预防或治疗药物。本发明涉及一种由以下公式（I）表示的化合物：其中每个符号如规范中所定义，或其盐。
• Selective acylation of a sterically hindered hydroxyl group of unsymmetrical diols containing a primary hydroxyl group such as 1,5-hexanediol in the presence of silica gel with acetyl chloride
  作者：Haruo Ogawa、Yuko Ide、Ryoichi Honda、Teiji Chihara

  DOI：10.1002/poc.622

  日期：2003.6

  selectively formed in the presence of silica gel with acetyl chloride by refluxing a suspension of unsymmetrical diols containing a primary hydroxyl group such as 1,5-hexanediol preadsorbed on silica gel. Such regioselectivity was observed through preferential adsorption via a primary hydroxyl group of the diols. Copyright © 2003 John Wiley & Sons, Ltd.

  在硅胶与乙酰氯的存在下，通过回流预吸附在硅胶上的含伯羟基的不对称二醇（如1,5-己二醇）的悬浮液，选择性地形成受阻更大的单乙酸酯。通过经由二醇的伯羟基的优先吸附观察到这种区域选择性。版权所有©2003 John Wiley＆Sons，Ltd.
• Aminopyrimidine compound
  申请人：Cardurion Pharmaceuticals, LLC

  公开号：US11130752B2

  公开（公告）日：2021-09-28

  The present invention provides a compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal arrhythmia) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

  本发明提供了一种具有 CaMKII 抑制作用的化合物，该化合物有望用作预防或治疗心脏疾病（特别是儿茶酚胺能多形性室性心动过速、术后心房颤动、心力衰竭、致命性心律失常）等的药物。 本发明涉及一种由式（I）代表的化合物： 其中各符号如说明书中所定义，或其盐类。
• [EN] AMINOPYRIMIDINE COMPOUND<br/>[FR] COMPOSÉ D'AMINOPYRIMIDINE
  申请人：CARDURION PHARMACEUTICALS LLC

  公开号：WO2020068854A1

  公开（公告）日：2020-04-02

  The present invention provides a compound having a CaMKII inhibitory action, which is expected to be useful as an agent for the prophylaxis or treatment of cardiac diseases (particularly catecholaminergic polymorphic ventricular tachycardia, postoperative atrial fibrillation, heart failure, fatal arrhythmia) and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
• Gold(I)/Copper(II)-Cocatalyzed Tandem Cyclization/Semipinacol Reaction: Construction of 6-<i>Aza/Oxa</i>-Spiro[4.5]decane Skeletons and Formal Synthesis of (±)-Halichlorine
  作者：Dao-Yong Zhu、Zhen Zhang、Xue-Qing Mou、Yong-Qiang Tu、Fu-Min Zhang、Jin-Bao Peng、Shao-Hua Wang、Shu-Yu Zhang

  DOI：10.1002/adsc.201400932

  日期：2015.3.9

  A simple and efficient strategy for the construction of 6‐aza/oxa‐spiro[4.5]decane skeletons under the cocatalysis of gold(I)/copper(II) was developed, and its potential utility was demonstrated by a formal synthesis of the biologically active marine alkaloid (±)‐halichlorine.

  提出了一种在金（I）/铜（II）的共催化下构建6-氮杂/氧杂-螺[4.5]癸烷骨架的简单有效策略，并且通过生物学上的正式合成证明了其潜在的实用性。活性海洋生物碱（±）-氯化氢。